Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Supplemental NDA filing for Abelcet

May 10, 1996

Nichinichi reports novel approach to antifungal Rx

May 10, 1996

Bayer claimes quinolones and naphthyridines

May 10, 1996

SKB's intranasal mupirocin now available in U.S.

May 10, 1996

Malaria vaccine lead reported by Johns Hopkins

May 3, 1996

Roche claims stable ganciclovir prodrugs

May 3, 1996

Cell Pharm to distribute Alferon N Injection in Germany

May 3, 1996

Amphotec efficacy data published

May 3, 1996

New fluoroquinolones from Korean institute

May 3, 1996

AmBisome launched in Spain

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 22, 2026.
Sangamo presents primate data for prion suppressor ST-506
BioWorld Science
Sangamo Therapeutics Inc. discussed gene regulation approaches for neurodegenerative diseases when presenting findings on their clinical candidate ST-506 for the...
TREM2 agonists detailed in Pfizer patent
BioWorld Science
Pfizer Inc. has reported new triggering receptor expressed on myeloid cells 2 (TREM2) agonists potentially useful for the treatment of neurodegeneration.
Selection Therapeutics identifies new Kv1.3 blockers
BioWorld Science
Selection Therapeutics GmbH has discovered new potassium voltage-gated channel subfamily A member 3 (KCNA3; Kv1.3) blockers potentially useful for the treatment...
Ignis Therapeutics synthesizes new muscarinic M4 receptor PAMs
BioWorld Science
Ignis Therapeutics (Suzhou) Co. Ltd. has patented new muscarinic M4 receptor positive allosteric modulators (PAMs) potentially useful for the treatment of...